EDGE^® DAPPv

EDGE^® DAPPv is a 0.5mL, combined vaccination approved for protection against canine distemper virus, adenovirus type 1 (hepatitis), canine parainfluenza virus, and canine parvovirus.

NOBIVAC^® EDGE^® DAPPv PROVIDES PROTECTION AGAINST FOUR KNOWN VIRUSES IN A 0.5 ML VACCINE

Canine Distemper Virus, Canine Adenovirus 1 (hepatitis), Canine Parainfluenza Virus, Canine Parvovirus (modified live viruses).

PRODUCT LABEL

Protects against all known strains of CPV, including CPV-2c^2,3
High antigenic mass (titer), low passage parvovirus vaccine
Canine vaccine containing CPV-2b, one of the most prevalent field strains of parvovirus
Protects against adenovirus type 1 that causes hepatitis in dogs
Provides disease coverage for commonly spread canine viruses, distemper, adenovirus types 1, parainfluenza and parvovirus in 1 formula

INDICATIONS:

Shown to be effective for the vaccination against distemper, adenovirus type 1 (hepatitis), parainfluenza, and parvovirus in one formula. Recommended for use in healthy dogs 6 weeks of age or older.

Efficacy & Comparisons

NOBIVAC^® EDGE^®DAPPv IS A SAFE CHOICE

Safety confirmed in 346-dog field study¹
Proven safe across a variety of dog breeds and ages

ADMINISTRATION AND DOSAGE

Subcutaneous injection
Primary vaccination may begin as early as 6 weeks
Repeat dose 2 to 4 weeks later. Two doses are required for primary immunization.
Historically, annual revaccination has been recommended for this product. The need for this booster has not been established.
Available in a 25 x 0.5 mL dose presentation

ALSO AVAILABLE IN OTHER FORMULATIONS

NOBIVAC^® EDGE^® DAPPv+L₄VACCINES

DISEASE INFORMATION

PROTECT AGAINST ALL KNOWN STRAINS OF CANINE PARVOVIRUS (CPV), INCLUDING CPV-2C²

PROVEN IN AN INDEPENDENT STUDY BY LARSON AND SCHULTZ²

No clinical signs of disease were seen in Nobivac-vaccinated puppies after challenge with mixed CPV-2b and CPV-2c strains²
First published data showing protection against CPV-2c challenge²
All vaccinated puppies were protected from disease
All control puppies developed disease and 50% died or were euthanized